fx-322
Small moleculeexperimental
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 30, 2017 (NCT03300687)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05086276 | Phase 2 | Oct 12, 2021 | Frequency Therapeutics |
| NCT04629664 | Phase 1 | Nov 2, 2020 | Frequency Therapeutics |
| NCT04601909 | Phase 1 | Sep 17, 2020 | Frequency Therapeutics |
| NCT04120116 | Phase 2 | Oct 4, 2019 | Frequency Therapeutics |
| NCT03616223 | Phase 1/Phase 2 (Phase 2) | Jul 3, 2018 | Frequency Therapeutics, Worldwide Clinical Trials |
| NCT03300687 | Early Phase 1 (Phase 1) | May 30, 2017 | Frequency Therapeutics |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Frequency Therapeutics | For profit | 6 | 6 | 2 | 2017 |
| Worldwide Clinical Trials | For profit | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1